Background illustration for clinical trials search

Paid Clinical Trials Missouri

Discover 1,809 paid clinical trials in Missouri. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

for
Small-cell Lung Cancer, Small Cell Lung Cancer Extensive Stage
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07545954

Phase 1, Recruiting

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

for
Multiple Sclerosis (MS) - Relapsing-remitting
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 40 - 70

Code: NCT07758270

Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: St Louis MO, Denver CO, Goodyear AZ, Irvine CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase 2, Recruiting

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

for
Pulmonary Arterial Hypertension
Location: New York NY, Philadelphia PA, Falls Church VA,
Sponsor: Gossamer Bio USA, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06274801

Phase 3, Recruiting

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Miami FL, Ocala FL, St Louis MO, Little Rock AR,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07701993

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: New York NY, Morehead City NC, Miami FL, Ocala FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07704892

Phase 3, Recruiting

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

for
Hypertriglyceridemia
Location: Quebec, Chicoutimi, Montreal, Little River SC,
Sponsor: Marea Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07028749

Phase 2, Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Zion IL, St Louis MO, Houston TX, Goodyear AZ,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07594106

Phase 1, Phase 2, Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

for
Carcinoma, Renal Cell
Location: Boston MA, New York NY, Morristown NJ, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07489495

Phase 3, Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

for
HIV Infections
Location: Annandale VA, Fort Lauderdale FL, West Palm Beach FL,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07682961

Phase 3, Recruiting

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Toronto, Knoxville TN, Atlanta GA, Nashville TN,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07544654

Phase 3, Recruiting

Eating Disorder Chatbot Optimization

for
Eating Disorders
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07218302

Phase 2, Recruiting

Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

for
Idiopathic Pulmonary Fibrosis
Location: The Bronx NY, Richmond VA, Miami FL,
Sponsor: Trevi Therapeutics

Sex: All

Age: 40+

Code: NCT07671911

Phase 3, Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for
Weight Management
Location: Truro, Moncton, Long Island City NY, Laurelton NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07667803

Phase 3, Recruiting

Stunting and Targeting Reduction of Impaired Growth in Kids Effectively

for
Malnutrition (Calorie)
Location: Kansas City MO
Sponsor: Abbott Nutrition

Sex: All

Age: 1 - 5

Code: NCT07524907

Recruiting

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for
Metastatic Malignant Solid Neoplasm,
Location: Boston MA, Pittsburgh PA, Gainesville FL, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05372614

Phase 1, Recruiting

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

for
Epiretinal Membrane, Dry Age Related Macular Degeneration,
Location: Portland ME, Fort Lauderdale FL, Kansas City MO,
Sponsor: Carl Zeiss Meditec-Dublin CoCe

Sex: All

Age: 18+

Code: NCT07680244

Recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

for
Acute Adult T-Cell Leukemia/Lymphoma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04301076

Phase 1, Recruiting

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

for
Recurrent Plasmablastic Lymphoma,
Location: Deerfield Beach FL, Hollywood FL, Coral Gables FL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07332507

Phase 1, Recruiting

Quality of End-of-Life Care for Children With Cancer

for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Providence RI, The Bronx NY, Albany NY, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 18+

Code: NCT07412002

Recruiting

Popular cities in Missouri

With its expansive healthcare network and renowned medical research institutions, Missouri is a central hub for a diverse range of clinical trials. Leading organizations such as Washington University School of Medicine in St. Louis, the University of Missouri Health Care, and St. Louis University are at the forefront of groundbreaking studies. These institutions drive innovation in medical research and offer unique opportunities for participants to engage in cutting-edge clinical trials, contributing to advancements in healthcare both locally and nationwide.

Why choose Missouri for clinical trials?

Missouri has a diverse population which ensures a wide variety of participants can take part in clinical trials, enhancing the accuracy, applicability, and validity of clinical research findings. The state is also home to a thriving research environment, with a strong emphasis on medical innovation and cutting-edge studies led by world-class institutions.

By choosing to participate in a clinical trial in Missouri, individuals contribute to critical advancements in medical research while benefiting from a well-established and supportive clinical research infrastructure.

Common conditions studied in Missouri

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Missouri